ActiGraft+ is an autologous, point-of-care wound management system created from your patient's whole blood. Once applied, the blood clot serves as a protective covering and optimizes the body's own healing potential.
RELIABLE OUTCOMES
Sustains a PAR rate of >/= 25% within 3 weeks of use and a 72% complete closure rate in 12 weeks.
COST-EFFECTIVE
Introducing ActiGraft+ into your facility can reduce woundcare spend up to 40%.
EASY-TO-MANAGE
Created using proprietary calcium gluconate powder that produces a thick, easy-to-apply whole blood clot.
SIMPLIFIED PROCESS
Needle-less blood transfer and 5-minute coagulation provides a clean, quick and easy preparation requiring no capital equipment.
PATIENT COMFORT
Fast healing with less wound interaction, increases patient satisfaction scores.
NATURAL HEALING
Provides the wound with an optimal, natural healing environment allowing the healing process to proceed unhindered.
ActiGraft can be used for a wide variety of hard-to-treat chronic wounds, including but not limited to:
Diabetic/Neuropathic ulcers
Pressure Ulcers/Injury
Venous Stasis Ulcers
Surgical Debridement wounds
Traumatic wounds
Skin Tears
ActiGraft is contraindicated in patients with the following types of wounds:
Wounds due to malignancy
Wounds with active clinically diagnosed infection
Radius of ActiGraft clot – 3cm (Diameter 6sq cm)
Clot size: 28.3sq cm
20ml of blood required
Storage conditions - Store in the original container at a room temperature of 5°C (41°F) – 30°C (86°F). Protect from freezing and avoid excessive heat.